Bioscience – Indianapolis Business Journal

Home » Bioscience

Indiana’s toxicology department sees more cases but shorter turnarounds amid staff shakeups

June 9, 2026

Jack Forrest, Indiana Capital Chronicle

The Indiana State Department of Toxicology saw an all-time high number of cases submitted for blood analysis in 2025.

0Comments

RayzeBio planning $150M in radiopharmaceutical facilities in Whitestown

June 1, 2026

Elissa Maudlin

The company, which is owned by biopharmaceutical giant Bristol Myers Squibb Co., is working on an incentive package with Whitestown officials that includes tax abatements for construction and new equipment for two buildings.

0Comments

Leaders hope name for Indiana’s biosciences ecosystem will help state share its story

May 19, 2026 | Daniel Bradley

The name BioHeartland was created to give Indiana “a more cohesive and unified way to share the state’s story with investors, companies, researchers and talent around the world,” officials said.

Work begins on Heartland BioWorks headquarters in Indy

May 18, 2026 | Alex Brown, Inside INdiana Business

The nearly $24.3 million project, being led by Bloomington-based Applied Research Institute, or ARI, will serve as a biomanufacturing workforce training and innovation center when complete.

Ossium Health aims to revolutionize role of bone marrow banks

April 17, 2026 | Daniel Bradley

The company has a goal to build a massive bank of bone marrow from deceased organ donors to treat patients with blood cancers and improve organ transplantations.

Braun: $1B state investment in Indiana’s life sciences expected to create 100K jobs

March 17, 2026 | Marek Mazurek

Seeking to position Indiana as a global leader in agritechnology and life sciences, Gov. Mike Braun unveiled a lofty goal in a public announcement Tuesday morning.

IU launches umbrella group for real estate, research and life sciences work

February 20, 2026 |

Mickey Shuey

IU Inc. was approved unanimously by the university’s board of trustees during its monthly meeting Friday in Indianapolis.

Indianapolis-based ag giant Corteva considering split-up, report says

September 13, 2025 | IBJ Staff

The $50 billion company is considering dividing its seed and pesticide businesses into separate companies, the Wall Street Journal reported

Indianapolis-based startup leans on connections to treat brain diseases

June 13, 2025 | Daniel Lee

Syndeio Biosciences sees burgeoning potential to treat mental health and cognitive conditions, including Alzheimer’s and depression, with therapies that target the almost countless minuscule brain synapses that give people the ability to think and function.

Indianapolis-based Gate Neurosciences to acquire California-based startup

February 19, 2025 |

Susan Orr

Indianapolis-based Gate Neurosciences, which is in clinical trials of a medicine to treat depression, plans to acquire California-based biotech startup Boost Neuroscience.

Commerce chief David Rosenberg to lead IU biosciences accelerator in Indy

January 9, 2025

Known as IU LAB and supported by a $138 million grant from the Lilly Endowment, the IU Launch Accelerator for Biosciences will be based at the 16 Tech Innovation District.

UPDATE: IU lands $138M grant from Lilly Endowment to fund new biosciences accelerator

December 12, 2024 |

John Russell

The gift is the largest grant that Indiana University has ever received in support of research and development. IU President Pamela Whitten said the funding will help “change the very landscape of our capital city and state.”

Corteva takes $25M stake in North Carolina gene-editing agriculture company

September 17, 2024 |

John Russell

Corteva, the Indianapolis-based seed and crop protection giant, formed a joint venture with the startup, Pairwise, based in Durham, North Carolina, aimed at increasing crop yield for food, fuel and fiber production.

MBX Biosciences files intention to go public

August 26, 2024 |

John Russell

The five-year-old, clinical-stage drugmaker has already raised more than $213 million to develop therapeutics to treat rare endocrine disorders, a huge amount for a startup.

Fast-growing MBX Biosciences raises another $63.5 million in funding

August 5, 2024 |

John Russell

MBX is focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, such as hypoparathyroidism, post-bariatric hypoglycemia and obesity.

Stevanato commits to paying Fishers employees a living wage

July 9, 2024 | Kylie Veleta, Inside INdiana Business

Stevanato, an Italian-based life sciences company that makes glass vials and syringes for pharmaceuticals, has committed to paying employees at its new Fishers facility no less than $70,000 annually. 

Indiana’s Heartland BioWorks Hub to receive $51M in CHIPS Act funding

July 2, 2024 | Cate Charron

Indiana’s Heartland BioWorks Hub was one of 12 hubs chosen to split $500 million in implementation funding stemming from the CHIPS and Science Act.

Roche to buy bowel drugmaker Telavant for $7.1 billion

October 24, 2023 | Bloomberg News

Roche has come under pressure to improve its pipeline with medicines it can commercialize soon as a windfall of revenue from products used in the COVID-19 pandemic comes to an end.

Biotech firm nearing completion of Indy radioisotopes factory

September 18, 2023 |

John Russell

Following a $45 million renovation, RayzeBio plans to use the plant to make Actinium 225, a radioisotope used for targeted therapy for cancer.

Purple maize: Hamilton County company helps corn warn of trouble

May 5, 2023 | Sam Stall

Kyle Mohler founded Insignum Agtech with the idea of rearranging bits of corn’s DNA, then inserting them into popular field-corn hybrids.

Life sciences industry booster BioCrossroads girds for new challenges

March 24, 2023 |

John Russell

Patricia Martin, the group’s president and CEO since 2019, last month announced she would step down to examine opportunities in the private sector and urged industry leaders to take a fresh look at the organization.

Musk’s company aims to soon test brain implant in people

December 1, 2022 | Associated Press

Elon Musk’s Neuralink is one of many groups working on linking brains to computers, efforts aimed at helping treat brain disorders, overcoming brain injuries and other applications.

JUNE 5-11, 2026

Digital Edition

Indianapolis Democrats weather first big test before mayor’s race

Taylor Wooten

Byrider back in gear after pandemic era struggles

Susan Orr

Q&A: Toyota Automated Logistics VP of people talks HQ move and new company

Joey Harris

Previous Issues See Full Issue

Events

IBJ will honor Indiana nonprofits, foundations, organization leaders, businesses who work with nonprofits and philanthropists at the inaugural Nonprofit Excellence Awards presented by KSM CPA & Advisors.

RSVP HERE!

More events

Nominations

IBJ’s 20 in their Twenties honors emerging leaders who are making an impact on their communities at the very start of their careers. These 20-somethings are entrepreneurs, engineers, volunteers and social justice advocates — and people who will continue to contribute in the decades ahead.

NOMINATE HERE!

IBJ will spotlight some of our city’s most successful business women from both the public and private sectors while revealing the triumphs and challenges that have shaped their careers.

NOMINATE HERE!